J. Bosch

发表

MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.

M. Lotem, B. Ksander, S. Ostrand-Rosenberg, 2007, Cancer research.

A Novel Model of Metastatic Conjunctival Melanoma in Immune-Competent Mice.

B. Ksander, C. Cursiefen, L. Heindl, 2015, Investigative ophthalmology & visual science.

Immunology of Uveal Melanoma: Adaptive Antitumor Immunity and the Basis for Immunotherapy

B. Ksander, J. Bosch, 2003 .

Advances in cellular therapy: 5th International Symposium on the clinical use of cellular products, 19 and 20 March 2009, Nürnberg, Germany

A. Mackensen, M. Aigner, R. Andreesen, 2010, Cancer Immunology, Immunotherapy.

Immunotherapy of uveal melanoma.

J. Bosch, 2012, Developments in ophthalmology.

Tumor Cell Programmed Death Ligand 1-Mediated T Cell Suppression Is Overcome by Coexpression of CD80

B. Ksander, S. Ostrand-Rosenberg, M. Srivastava, 2011, The Journal of Immunology.

by Coexpression of CD80 1-Mediated T Cell Suppression Is Overcome Tumor Cell Programmed Death Ligand

B. Ksander, S. Ostrand-Rosenberg, J. Bosch, 2011 .

[New Therapeutic Approaches in Inflammatory Diseases of the Eye - Targeting Lymphangiogenesis and Cellular Immunity: Research Unit FOR 2240 Presents Itself].

A. Heiligenhaus, T. Langmann, T. Clahsen, 2017, Klinische Monatsblatter fur Augenheilkunde.

Activation of Tumor-specific CD4+ T Lymphocytes by Major Histocompatibility Complex Class II Tumor Cell Vaccines

Peter W. Chen, B. Ksander, S. Ostrand-Rosenberg, 2004, Cancer Research.

Characterization of CD4+ T cells primed and boosted by MHCII primary uveal melanoma cell-based vaccines

A. Mackensen, L. Heindl, I. Atreya, 2019, Oncotarget.

Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.

G. Naumann, F. Kruse, C. Cursiefen, 2011, Ophthalmology.

Tumor-associated lymphangiogenesis in the development of conjunctival melanoma.

G. Naumann, F. Kruse, C. Cursiefen, 2011, Investigative ophthalmology & visual science.

Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2

N. Klopp, P. Kremsner, M. Fotin‐Mleczek, 2021, Wiener klinische Wochenschrift.

Antigen-Specific Transfer of Functional Programmed Death Ligand 1 from Human APCs onto CD8+ T Cells via Trogocytosis

A. Mackensen, E. Ullrich, Simon Voelkl, 2012, The Journal of Immunology.

T Cells via Trogocytosis + onto CD8 Programmed Death Ligand 1 from Human APCs Antigen-Specific Transfer of Functional

A. Mackensen, E. Ullrich, Simon Voelkl, 2012 .

The novel role of lymphatic vessels in the pathogenesis of ocular diseases

Björn J. Bachmann, T. Clahsen, B. Schumacher, 2023, Progress in Retinal and Eye Research.

Midkine promotes metastasis and therapeutic resistance via mTOR/RPS6 in uveal melanoma.

A. Mackensen, B. Ksander, L. Heindl, 2022, Molecular cancer research : MCR.

Comparing the Hem- and Lymphangiogenic Profile of Conjunctival and Uveal Melanoma Cell Lines.

M. Jager, C. Cursiefen, L. Heindl, 2015, Investigative ophthalmology & visual science.

Autocrine impact of VEGF-A on uveal melanoma cells.

C. Cursiefen, L. Heindl, Deniz Hos, 2014, Investigative ophthalmology & visual science.

[Novel Adjuvant Therapy for Ocular Melanoma].

L. Heindl, J. Bosch, 2017, Klinische Monatsblatter fur Augenheilkunde.

The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes

B. Ksander, S. Ostrand-Rosenberg, Suzanne Ostrand-Rosenberg, 2008, Cancer Immunology, Immunotherapy.

Hydrogen-Peroxide Synthesis and LDL-Uptake Controls Immunosuppressive Properties in Monocyte-Derived Dendritic Cells

A. Mackensen, D. Mougiakakos, Simon Voelkl, 2021, Cancers.

Inflammatory Aneurysm of the Common Iliac Artery Mimicking Appendicitis

J. Hamming, J. Mieog, J. Stoot, 2008, Vascular.

Lung cancer patients’ CD4+ T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells

M. Edelman, B. Ksander, S. Ostrand-Rosenberg, 2008, Cancer Immunology, Immunotherapy.

Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells

M. Lotem, B. Ksander, S. Reid, 2009, Cancer Immunology, Immunotherapy.

MHC II lung cancer vaccines prime and boost tumor‐specific CD4+ T cells that cross‐react with multiple histologic subtypes of nonsmall cell lung cancer cells

M. Edelman, S. Ostrand-Rosenberg, Ashley L. Wilson, 2010, International journal of cancer.

Time-of-flight magnetic flow cytometry in whole blood with integrated sample preparation.

Eckhard Quandt, Oliver Hayden, Mathias Reisbeck, 2013, Lab on a chip.

Impaired Transmigration of Myeloid-Derived Suppressor Cells across Human Sinusoidal Endothelium Is Associated with Decreased Expression of CD13

Daniel F Gilbert, C. Weston, S. Curbishley, 2017, The Journal of Immunology.

Monitoring dynamic interactions of tumor cells with tissue and immune cells in a lab-on-a-chip.

Verena Charwat, Peter Ertl, Paul Muellner, 2013, Analytical chemistry.

Characterization and Quantitation of the Tumor Microenvironment of Uveal Melanoma

J. Bosch, N. Refaian, Ludwig M Heindl, 2023, Biology.

Phase 1 Assessment of the Safety and Immunogenicity of an mRNA- Lipid Nanoparticle Vaccine Candidate Against SARS-CoV-2 in Human Volunteers

P. Kremsner, M. Fotin‐Mleczek, G. Leroux-Roels, 2020, medRxiv.

The Trojan Horse Tale Revisited: An Eye on Metastatic Spread of Carcinoma Cells

C. Cursiefen, L. Heindl, H. Bruns, 2015, Cancer Immunology Research.

Neue Therapieansätze bei entzündlichen Augenerkrankungen durch Modulation von Lymphangiogenese und zellulärer Immunität: Die DFG-Forschergruppe 2240 stellt sich vor

A. Heiligenhaus, T. Langmann, T. Clahsen, 2017, Klinische Monatsblätter für Augenheilkunde.